Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Rigel Pharmaceuticals, Inc. - Common Stock
(NQ:
RIGL
)
38.70
+1.27 (+3.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rigel Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Friday's Intraday Session
↗
December 02, 2022
Via
Benzinga
Why Are Chinese Stocks BABA, BILI, IQ Up Today?
↗
December 02, 2022
Chinese stocks are climbing higher on Friday as investors continue to hope that the country will ease off of Covid-19 restrictions.
Via
InvestorPlace
BBWI Stock Climbs as Bath & Body Works Candle Day Sale Kicks Off
↗
December 02, 2022
Bath & Body Works (BBWI) stock is rising higher on Friday as the retail company starts its annual Candle Day sale with a deep discount.
Via
InvestorPlace
Gold Down 1%; Samsara Shares Spike Higher
↗
December 02, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday.
Via
Benzinga
Rigel Pharmaceuticals (RIGL) Stock Soars on FDA Approval News
↗
December 02, 2022
Rigel Pharmaceuticals (RIGL) stock is heading higher on Friday after getting approval from the FDA for its leukemia treatment.
Via
InvestorPlace
Another Clinical Trial Setback For Rigel Pharma's Lead Program, This Time For COVID-19
↗
November 02, 2022
Via
Benzinga
Expert Ratings for Rigel Pharmaceuticals
↗
August 17, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) has observed the following analyst ratings within the last quarter:
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 02, 2022
Via
Benzinga
Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket
↗
December 02, 2022
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
December 02, 2022
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!
Via
InvestorPlace
Earnings Scheduled For November 3, 2022
↗
November 03, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Via
Benzinga
Preview: Rigel Pharmaceuticals's Earnings
↗
November 02, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel...
Via
Benzinga
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
↗
November 02, 2022
Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022.
Via
Benzinga
Nasdaq Drops 150 Points; AZZ Shares Plummet
↗
October 11, 2022
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 150 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 11, 2022
Gainers
Via
Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
↗
October 12, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
Via
Benzinga
Dow Surges Over 100 Points; Crude Oil Down 2%
↗
October 11, 2022
U.S. stocks pared some losses midway through trading, with the Dow Jones gaining more than 100 points on Tuesday.
Via
Benzinga
Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
↗
October 11, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 11, 2022
Gainers DICE Therapeutics (NASDAQ:DICE) stock moved upwards by 83.4% to $45.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.7 billion.
Via
Benzinga
Rigel Pharma Drops FDA Submission Plans For Expanded Use Of Its Lead Product
↗
October 11, 2022
Rigel Pharmaceuticals Inc (NASDAQ: RIGL) received guidance from the FDA's review of its re-analysis of data from the FORWARD Phase 3 trial of fostamatinib for warm autoimmune hemolytic anemia...
Via
Benzinga
Why Leggett & Platt Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
↗
October 11, 2022
Gainers Vox Royalty Corp. (NASDAQ: VOXR) rose 60.4% to $4.33 in pre-market trading. Vox Royalty’s common shares commenced trading on The Nasdaq Stock Market on Monday.
Via
Benzinga
iQIYI, Las Vegas Sands And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
↗
October 11, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 10, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.
Via
Benzinga
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
↗
August 24, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 18, 2022
Via
Benzinga
Piper Sandler Maintains Neutral Rating for Rigel Pharmaceuticals: Here's What You Need To Know
↗
August 17, 2022
Piper Sandler has decided to maintain its Neutral rating of Rigel Pharmaceuticals (NASDAQ:RIGL) and raise its price target from $1.00 to $2.00. Shares of Rigel Pharmaceuticals are trading up 1.12%...
Via
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
↗
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Rigel Pharma Expands Blood Cancer Portfolio With Forma Therapeutics Licensing Pact
↗
August 03, 2022
Via
Benzinga
Rigel Pharmaceuticals: Q2 Earnings Insights
↗
August 02, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
↗
August 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
